(+/-)-1-[(2'-BETA,3'-BETA,5'-BETA)-2'-ACETOXY-5'-(ACETOXYMETHYL)-THIAN-3'-YL]-2,4(1H,3H)-PYRIMIDINEDIONE
Compound with spectra: 1 NMR
![(+/-)-1-[(2'-BETA,3'-BETA,5'-BETA)-2'-ACETOXY-5'-(ACETOXYMETHYL)-THIAN-3'-YL]-2,4(1H,3H)-PYRIMIDINEDIONE](/api/compound/CjZp4VZeBjq.png?ph=true&h=300&w=458 "(+/-)-1-[(2'-BETA,3'-BETA,5'-BETA)-2'-ACETOXY-5'-(ACETOXYMETHYL)-THIAN-3'-YL]-2,4(1H,3H)-PYRIMIDINEDIONE")
| SpectraBase Compound ID | CjZp4VZeBjq |
|---|---|
| InChI | InChI=1S/C14H18N2O6S/c1-8(17)21-6-10-5-11(13(23-7-10)22-9(2)18)16-4-3-12(19)15-14(16)20/h3-4,10-11,13H,5-7H2,1-2H3,(H,15,19,20)/t10-,11-,13+/m1/s1 |
| InChIKey | OYOKALNSIVOCMJ-WZRBSPASSA-N |
| Mol Weight | 342.37 g/mol |
| Molecular Formula | C14H18N2O6S |
| Exact Mass | 342.088557 g/mol |
| Enantiomer InChIKey | OYOKALNSIVOCMJ-GMXVVIOVSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | PYRIDINE-D5 |
Cyclopentaneacetic acid, 4-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-2,3-dihydroxy-, ethyl ester, [1S-(1.alpha.,2.beta.,3.beta.,4.alpha.)]-
1-[(1S,2R,4R,5R)-4-methylol-3-oxa-6-thiabicyclo[3.1.0]hexan-2-yl]pyrimidine-2,4-quinone
1-(2',3'-Dideoxy-2',3'-epithio-B-D-lyxo-furanosyl)-uracil
1-[(1R,2R,4R,5S)-4-methylol-3-oxa-6-thiabicyclo[3.1.0]hexan-2-yl]pyrimidine-2,4-quinone
OLUKXWWJVTWVQB-ZITKLIBNSA-N
1-[(2R,3R,4S,5S)-4-hydroxy-5-methylol-3-(methylthio)tetrahydrofuran-2-yl]pyrimidine-2,4-quinone
WFGZGVFNINQBOW-MGHWNKPDSA-N
1-(2S,4R,5R)-4-[(benzoyloxy)methyl]-5-[2-(acetylthio)ethyl]tetrahydrofuran-2-yl]uracil
1-(2R,4S,5S)-4-[(benzoyloxy)methyl]-5-[2-(acetylthio)ethyl]tetrahydrofuran-2-yl]uracil
1-(3-Amino-2,5-anhydro-3-deoxy-B-D-arabinofuranosyl)-uracil
| Title | Journal or Book | Year |
|---|---|---|
| Heterocyclic analogs of nucleosides: synthesis and biological evaluation of some 1-(3-thianyl)uracil and 9-(3-thianyl)adenine derivatives | Canadian Journal of Chemistry | 1994 |